Browse/search for people

Professor Imre Berger


Imre Berger was trained as a biochemist and synthetic biologist at Leibniz University and Medical School (MHH) in Hannover (Germany), at MIT (Cambridge, USA), and at ETH Zurich (Switzerland). His team develops enabling methods for DNA delivery and genome engineering, and researches the structure and mechanism of multiprotein complexes in human health and disease.

After Group Leader posts at ETH (2005) and EMBL (2007), Berger was appointed in 2014 Full Professor at the School of Biochemistry, University of Bristol, UK. Since 2017 he is Director of the BBSRC/EPSRC research centre for synthetic biology at Bristol, BrisSynBio and Co-director of the Bristol Biodesign Institute BBI. Since 2019, Berger is Director of the Max Planck Centre for Minimal Biology in Bristol.

Imre Berger developed the MultiBac, ACEMBL and ComplexLink systems for multigene delivery and multiprotein research, which are in use in some of the best laboratories world-wide. He holds international patents for DNA and protein technologies, co-founded three biotech companies and received numerous distinctions, including the Swiss Technology Award, the W.A. DeVigier Foundation Award, and a Wellcome Trust Senior Investigator Award for his innovative research. Since 2019, Berger is Investigator of the European Research Council (ERC).

Prof. Berger has participated in leading roles in numerous European Commission (EC) projects, including INSTRUCT, the pan-European infrastructure for structural biology. Berger has been Coordinator of the EC FP7 HEALTH ComplexINC project enhancing production tools for next-generation complex biologics in academic and industrial R&D  (2011-2016). He is partner in the EPSRC funded Innovative Future Vaccine Manufacturing hub. 



School of Biochemistry

Other sites

School of Biochemistry staff